McArdle Disease
10
0
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (10)
Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.
Carbon-13 Magnetic Resonance Spectroscopy in Glycogen Storage Diseases
Modified Ketogenic Diet in Patients With McArdle Disease Part B
Ketogenic Diet Survey in Patients With McArdle Disease (GSDV)
Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases
A Study of the Safety of REN001 in Patients With McArdle Disease
Oral Ketone Body Supplementation in Patients With McArdle Disease
Muscle Relaxation in Myopathies With Positive Muscle Phenomena
Modified Ketogenic Diet in Patients With McArdle Disease Part A
Sodium Valproate for GSDV